The docosahexaneoic acid (DHA) Oxford Learning and Behaviour (DOLAB) Study
Not Applicable
Completed
- Conditions
- earning and behaviour in childrenNutritional, Metabolic, EndocrineSpecific developmental disorders of scholastic skills
- Registration Number
- ISRCTN99771026
- Lead Sponsor
- niversity of Oxford (UK)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 360
Inclusion Criteria
1. Children (both males and females) aged 7 - 9 years from mainstream state schools who are underperforming in literacy skills according to nationally standardised assessments of scholastic achievement at age 7 years (Key Stage 1). To be eligible, children must score below the 33rd centile for reading/writing, but within the normal range in at least one other domain.
2. English as a first language
Exclusion Criteria
1. Major learning disabilities or medical disorders
2. Taking medications expected to affect behaviour and learning
3. Taking fish oils already, or eating fish two times or more a week
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Children's age-standardised scores for behaviour (teacher ratings of attention deficit hyperactivity disorder [ADHD]-type symptoms) and learning (reading performance and working memory), assessed post-intervention. The following validated measures will be used: <br>1. Conners Teacher and Parent Ratings (CTRS-L and CPRS-L) <br>2. British Ability Scale (BAS II): Word reading <br>3. British Ability Scale (BAS II): Recall of Digits
- Secondary Outcome Measures
Name Time Method Correlations between changes in omega-3 (DHA) status and the primary outcomes plus any post-intervention changes in sleep (Combined Sleep Disturbance Index, and in 10% subset monitored objectively with actigraphy, sleep latency and duration).